De Maio, Flavio
 Distribuzione geografica
Continente #
NA - Nord America 4.446
EU - Europa 3.641
AS - Asia 3.270
SA - Sud America 663
AF - Africa 110
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.147
Nazione #
US - Stati Uniti d'America 4.285
SG - Singapore 1.480
IT - Italia 922
DE - Germania 752
CN - Cina 673
BR - Brasile 548
SE - Svezia 442
FR - Francia 372
VN - Vietnam 330
PL - Polonia 314
FI - Finlandia 152
GB - Regno Unito 152
IE - Irlanda 132
IN - India 110
HK - Hong Kong 106
ID - Indonesia 105
JP - Giappone 93
BD - Bangladesh 91
CA - Canada 86
UA - Ucraina 63
AT - Austria 62
RU - Federazione Russa 61
TR - Turchia 53
MX - Messico 51
AR - Argentina 50
NL - Olanda 45
IQ - Iraq 39
ZA - Sudafrica 38
ES - Italia 33
CH - Svizzera 30
KR - Corea 29
MA - Marocco 29
TW - Taiwan 25
BE - Belgio 22
IR - Iran 21
CZ - Repubblica Ceca 19
EC - Ecuador 17
PK - Pakistan 17
GR - Grecia 16
LT - Lituania 15
SA - Arabia Saudita 15
CL - Cile 13
UZ - Uzbekistan 13
CI - Costa d'Avorio 12
VE - Venezuela 12
PH - Filippine 11
IL - Israele 10
JO - Giordania 10
AU - Australia 9
KE - Kenya 8
AE - Emirati Arabi Uniti 7
CO - Colombia 6
DO - Repubblica Dominicana 6
EG - Egitto 6
TN - Tunisia 6
UY - Uruguay 6
AZ - Azerbaigian 5
HU - Ungheria 5
PE - Perù 5
DZ - Algeria 4
HN - Honduras 4
KZ - Kazakistan 4
PA - Panama 4
PY - Paraguay 4
RO - Romania 4
RS - Serbia 4
BH - Bahrain 3
DK - Danimarca 3
EE - Estonia 3
KG - Kirghizistan 3
NP - Nepal 3
VA - Santa Sede (Città del Vaticano) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
CR - Costa Rica 2
ET - Etiopia 2
EU - Europa 2
JM - Giamaica 2
LI - Liechtenstein 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
GA - Gabon 1
GE - Georgia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
Totale 12.136
Città #
Singapore 820
Ashburn 471
Chandler 468
San Jose 387
Warsaw 215
New York 184
Rome 184
Munich 157
Chicago 148
Beijing 134
Los Angeles 132
Dublin 130
The Dalles 121
Ho Chi Minh City 99
Hong Kong 98
Milan 97
Lauterbourg 91
Tokyo 91
Hefei 86
Helsinki 85
Kraków 84
Jakarta 76
Hanoi 75
Frankfurt am Main 72
Ann Arbor 69
Council Bluffs 69
Fairfield 62
Wilmington 62
Dallas 61
Cattolica 60
Boardman 58
São Paulo 58
San Mateo 55
Houston 52
Marseille 50
Seattle 48
Woodbridge 46
North Bergen 45
Vienna 44
Boston 43
Jacksonville 43
Nanjing 43
Princeton 40
Moscow 36
Orem 33
Lappeenranta 32
Guangzhou 31
Nuremberg 31
Nürnberg 31
Buffalo 30
Santa Clara 30
Denver 29
Kent 29
London 29
Seoul 28
Appignano 27
Montreal 27
Atlanta 26
Brooklyn 26
Cambridge 25
Chennai 25
Dearborn 22
Redwood City 22
Bremen 21
Paris 21
Phoenix 21
Brussels 20
Da Nang 20
Washington 20
Zurich 20
Johannesburg 19
Rio de Janeiro 19
Shanghai 19
Toronto 19
Stockholm 18
Andover 16
Dong Ket 16
Düsseldorf 16
Mexico City 16
Amsterdam 15
Falls Church 15
Izmir 15
Haiphong 14
Salt Lake City 14
Tianjin 14
Turku 14
Ankara 13
Abidjan 12
Brno 12
Iesi 12
Lawrence 12
Macerata 12
Manchester 12
Poplar 12
San Francisco 12
Augusta 11
Bexley 11
Falkenstein 11
Pune 11
Senigallia 11
Totale 6.648
Nome #
PE_PGRS33 Contributes to Mycobacterium tuberculosis Entry in Macrophages through Interaction with TLR2 356
ESISTE UNA CORRELAZIONE TRA ENERGIA, QUALITÀ DELL'ARIA INDOOR E COMFORT? L’ESPERIENZA DEL PROGETTO INTERNAZIONALE SEARCH II 350
Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne: a Nine-Year Experience at a Large Italian Teaching Hospital 294
Unraveling the Gut Microbiome–Diet Connection: Exploring the Impact of Digital Precision and Personalized Nutrition on Microbiota Composition and Host Physiology 281
Comparative Evaluation of BD Phoenix and Vitek 2 Systems for Species Identification of Common and Uncommon Pathogenic Yeasts 251
Optimized Use of the MALDI BioTyper System and FilmArray BCID Panel for the Direct Identification of Microbial Pathogens from Positive Blood Cultures 249
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 247
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 208
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 207
Comparison of Mycoplasma IES, Mycofast Revolution and Mycoplasma IST2 to detect genital mycoplasmas in clinical samples. 204
Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis 195
Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections 189
Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis 187
3D-printed graphene polylactic acid devices resistant to SARS-CoV-2: Sunlight-mediated sterilization of additive manufactured objects 185
Impact of pe_pgrs33 gene polymorphisms on mycobacterium tuberculosis infection and pathogenesis 183
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 176
Immunopathology of SARS-CoV-2 Infection: A Focus on T Regulatory and B Cell Responses in Children Compared with Adults 173
Commercially available CD4 + and CD8 + IFN-γ release assays combined with an HBHA-induced IGRA improve the characterization of the tuberculosis spectrum and monitoring of treatment in children 172
Structural determinants driving the binding process between PDZ domain of wild type human PALS1 protein and SLiM sequences of SARS-CoV E proteins 171
Direct MALDI-TOF MS Testing from Positive Blood Cultures for Rapid Identification of Bloodstream Infection-Causing Anaerobic Bacteria 168
PDZ2-conjugated-PLGA nanoparticles are tiny heroes in the battle against SARS-CoV-2 167
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 165
Epidemiology of group A streptococcal infection: are we ready for a new scenario? 164
Celiac Disease Predisposition and Genital Tract Microbiota in Women Affected by Recurrent Pregnancy Loss 162
PE-PGRS33 contributes to Mycobacterium tuberculosis entry in macrophages through interaction with TLR2 158
PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis 158
Multicenter Evaluation of Anyplex Plus MTB/NTM MDR-TB Assay for Rapid Detection of Mycobacterium tuberculosis Complex and Multidrug-Resistant Isolates in Pulmonary and Extrapulmonary Specimens 155
Pilot study on cultural and metagenomic analysis of bile and biliary stents lead to unveiling the key players in stent occlusion 154
Laser-Mediated antibacterial effects of Few- and Multi-Layer Ti3C2Tx MXenes 154
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 148
Vacuum-assisted closure (VAC®) systems and microbiological isolation of infected wounds 144
Impact of protein domains on PE_PGRS30 polar localization in Mycobacteria 143
Accuracy of QuantiFERON-TB Gold-PLUS Test for the Diagnosis of Mycobacterium tuberculosis infection in Children 142
Microbial signature of plaque and gut in acute coronary syndrome 139
Graphene–Curcumin Coatings Resistant to SARS-CoV-2 and Mycobacteria for the Production of Personal Protective Equipment 139
Risk Factors for Mortality in Adult COVID-19 Patients Who Develop Bloodstream Infections Mostly Caused by Antimicrobial-Resistant Organisms: Analysis at a Large Teaching Hospital in Italy 139
Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients 138
Re-evaluating positive serum samples for SARS-CoV-2-specific IgA and IgG antibodies using an in-house serological assay 138
International consensus statement on microbiome testing in clinical practice 137
PE_PGRS3 ensures provision of the vital phospholipids cardiolipin and phosphatidylinositols by promoting the interaction between M. tuberculosis and host cells 137
Simplified Testing Method for Direct Detection of Carbapenemase-Producing Organisms from Positive Blood Cultures Using the NG-Test Carba 5 Assay 136
Unraveling the Gut Microbiota: Implications for Precision Nutrition and Personalized Medicine 135
Rapid Detection of the Omicron (B.1.1.529) SARS-CoV-2 Variant Using a COVID-19 Diagnostic PCR Assay 135
The Relationship Between Maternal and Neonatal Microbiota in Spontaneous Preterm Birth: A Pilot Study 134
Verification of the Vitek Reveal System for Direct Antimicrobial Susceptibility Testing in Gram-Negative Positive Blood Cultures 131
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings 128
Two-Period Study Results from a Large Italian Hospital Laboratory Attesting SARS-CoV-2 Variant PCR Assay Evolution 127
Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children 127
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 124
Evaluation of Novel Guanidino-Containing Isonipecotamide Inhibitors of Blood Coagulation Factors against SARS-CoV-2 Virus Infection 120
Characterization of Metallo β-Lactamase Producing Enterobacterales Isolates with Susceptibility to the Aztreonam/Avibactam Combination 120
Comparative Fecal Microbiota Analysis of Infants With Acute Bronchiolitis Caused or Not Caused by Respiratory Syncytial Virus 119
Rapid and safe one-step extraction method for the identification of Brucella strains at genus and species level by MALDI-TOF mass spectrometry 117
Graphene nanoplatelet and graphene oxide functionalization of face mask materials inhibits infectivity of trapped SARS-CoV-2 117
Unraveling the potential of graphene quantum dots against Mycobacterium tuberculosis infection 116
Evaluation of Everolimus Activity against Mycobacterium tuberculosis Using In Vitro Models of Infection 116
First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness 116
Evaluation of the Toxic Activity of the Graphene Oxide in the Ex Vivo Model of Human PBMC Infection with Mycobacterium tuberculosis 115
First case of bacteremic liver abscess caused by an ST260-related (ST1861), hypervirulent Klebsiella pneumoniae 113
Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin 112
IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay 112
Characterization of gut microbiota in patients with metabolic syndrome candidates for bariatric/metabolic surgery: Preliminary findings of a multi-center prospective study 110
Graphene oxide-linezolid combination as potential new anti-tuberculosis treatment 110
Reemergence of Streptococcus pyogenes Infections in a Large Italian Hospital: A déjà vu from past Years 108
Evaluation of PE_PGRS33 as a potential surface target for humoral responses against Mycobacterium tuberculosis 108
Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites 107
Profiling the gut microbiota to assess infection risk in Klebsiella pneumoniae-colonized patients 106
Gut Microbiome Diversity and Composition Correlates With Time in the Therapeutic Range in Patients on Warfarin Treatment: A Pilot Study 105
Increasing Detection of Legionnaires’ Disease in a Large Italian Hospital in the Period 2016–2023 101
Enhanced chemotherapy for glioblastoma multiforme mediated by functionalized graphene quantum dots 101
Profiling the Urobiota in a Pediatric Population with Neurogenic Bladder Secondary to Spinal Dysraphism 100
In situ N-acetylcysteine release from polyvinyl alcohol film for moisture-activated food packaging 99
Immune characterization of the HBHA-specific response in mycobacterium tuberculosis-infected patients with or without HIV infection 95
Optimized Use of the MALDI BioTyper System and the FilmArray BCID Panel for Direct Identification of Microbial Pathogens from Positive Blood Cultures 93
Recommendations for accurate genotyping of SARS-CoV-2 using amplicon-based sequencing of clinical samples 90
Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection 89
Original Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross -protection against COVID-19 88
Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients 87
Structural Basis of PE_PGRS Polymorphism, a Tool for Functional Modulation 86
The Mycobacterial HBHA Protein: a Promising Biomarker for Tuberculosis 82
First bloodstream infection caused by Prevotella copri in a heart failure elderly patient with Prevotella-dominated gut microbiota: a case report 82
PE_PGRS proteins of Mycobacterium tuberculosis: A specialized molecular task force at the forefront of host–pathogen interaction 78
Face masks and nanotechnology: Keep the blue side up 73
Profiling the Gastrointestinal Microbiota 70
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings 64
Short-term gut microbiota's shift after laparoscopic Roux-en-Y vs one anastomosis gastric bypass: results of a multicenter randomized control trial 56
Role of Next-Generation Sequencing in Excluding the Nosocomial Origin of a Case of Legionnaires’ Disease Integrating Environmental Surveillance and Clinical Diagnosis 8
Establishment of Patient-Derived Organoids from Hepatocellular Carcinoma: Preliminary Data on Yield, Histopathological Concordance, and Methodological Challenges 6
Elucidating the role of group A Streptococcus genomics and pharyngeal microbiota in acute paediatric pharyngitis 4
Bladder Microbiota Snapshots Help to Monitor Urinary Tract Infections in Vulnerable Patients 4
Bloodstream infection by Lactobacillus rhamnosus in a haematology patient: why metagenomics can make the difference 3
Informed Therapeutic Microbiome Modulation for Post-Infectious Irritable Bowel Syndrome: Pilot Experience of a Microbiome Clinic 3
The Interplay Between the Gut Microbiota and Colorectal Cancer: A Review of the Literature 2
Characterization of the Effect of α-Lipoic Acid in Human Macrophages Infected with Mycobacterium tuberculosis 1
Detection of β-lactam resistance genes in Gram-negative bacteria from positive blood cultures using a microchip-based molecular assay 1
Comparative genomic analysis of bacteriocin genes in Lactobacillus crispatus strains 1
From paediatric rebound to adult redistribution: changing the epidemiology of group A Streptococcus after COVID-19 1
The invasive GAS puzzle in Italy: genomic insights from a hospital cohort in a fragmented surveillance landscape 1
Detection of ARGs from Gram-Negative Bacteria in Positive Blood Cultures Using a Microarray-Based System: Towards a Molecular Antibiotic Susceptibility Assay 1
Totale 12.321
Categoria #
all - tutte 48.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.967


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 0 0 0 45
2021/2022609 36 23 29 45 21 28 18 92 38 46 118 115
2022/20231.486 200 180 91 201 82 163 69 98 145 121 94 42
2023/2024998 50 184 31 57 51 158 89 29 23 61 115 150
2024/20252.305 95 53 128 107 136 110 139 119 346 247 447 378
2025/20265.170 691 155 324 689 910 287 846 248 359 318 187 156
Totale 12.321